Factors associated with effects of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory low-grade B cell non-Hodgkin lymphoma: single-institution experience with 94 Japanese patients in rituximab era
Crossref DOI link: https://doi.org/10.1007/s12185-014-1636-5
Published Online: 2014-08-21
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Uike, Naokuni
Choi, Ilseung
Tsuda, Mariko
Haji, Shojirou
Toyoda, Kousuke
Suehiro, Youko
Abe, Yasunobu
Hayashi, Toshinobu
Sawamoto, Hirofumi
Kaneko, Koichiro
Shimokawa, Mototsugu
Nakagawa, Makoto
Text and Data Mining valid from 2014-08-21